NCT02530307View on ClinicalTrials.gov

HT-3951 vs. Placebo in Stroke Rehabilitation

PHASE2TerminatedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Ischemic Stroke
Interventions
DRUG

HT-3951

DRUG

Placebo

Trial Locations (18)

Unknown

Phoenix

Scottsdale

Downey

Glendale

Loma Linda

Orlando

Chicago

Grand Rapids

Kansas City

West Orange

New York

White Plains

Charlotte

Tulsa

Portland

Elkins Park

Dallas

Houston

Sponsors
All Listed Sponsors
lead

Dart NeuroScience, LLC

INDUSTRY

NCT02530307 - HT-3951 vs. Placebo in Stroke Rehabilitation | Biotech Hunter | Biotech Hunter